| 16.12.2010 | Evolva initiates multiple ascending dose study with EV-077 | Press release |
| 13.12.2010 | Evolva extension of lock-up and coordinated sale | Press release |
| 01.12.2010 | SuppreMol Series C-Finanzierungsrunde | Press release |
| 01.12.2010 | SuppreMol closes Series C Financing Round | Press release |
| 14.09.2010 | Okairòs raises EUR 16 Mio. in Series B Financing | Press release |
| 19.04.2010 | SuppreMol erhält Orphan Drug Status für SM101 in den USA | Press release |
| 19.04.2010 | SuppreMol receives U.S. Orphan Drug Designation for SM101 | Press release |
| 12.04.2010 | Phase Ib/IIa clinical trial of SuppreMol GmbH | Press release |
| 12.04.2010 | SuppreMol beginnt klinische Phase Ib/IIa Studie mit SM101 | Press release |
| 25.01.2010 | BioMedPartners verstärkt ihr Management Team | Press release |
| 12.01.2010 | Final Closing of BioMedInvest II LP | Press release |
| 12.01.2010 | Finales Closing der BioMedInvest II LP | Press release |